0
Article |

Meningitis Occurring During Therapy for Otitis Media With Cephalexin and Cefaclor FREE

HAROLD S. RAUCHER, MD; RAMON J. C. MURPHY, MD; ASHER BARZILAI, MD
Am J Dis Child. 1982;136(8):745-746. doi:10.1001/archpedi.1982.03970440089029.
Text Size: A A A
Published online

Oral preparations of cephalosporins are often prescribed for the treatment of otitis media in children. These drugs are usually recommended after failure of therapy with other antibiotics.1 However, many practitioners began treatment of otitis with cefaclor (Ceclor) or cephalexin monohydrate (Keflex). Both cephalexin and cefaclor have a pleasant taste and are effective against common middle ear pathogens including most strains of Haemophilus influenzae and Staphylococcus aureus. Cefaclor is more effective than ampicillin against β-lactamase-producing H influenzae strains.

An objection to the use of oral cephalosporins in infants and young children is their poor penetration of the blood-brain barrier, resulting in a low drug concentration in the CSF. We report a case of pneumococcal meningitis in a child who was receiving cefaclor and a case of H influenzae meningitis in a child who was receiving cephalexin therapy.

Report of Cases.—Case 1.—A 6-month-old boy was brought to his pediatrician

REFERENCES

Ginsburg CM, McCracken GH Jr:  Cefaclor and cefadroxil: A commentary on their properties and possible indications for use in pediatrics . J Pediatr 1980;;96:340-342.
Anhalt JP, Sabath LD, Barry AL:  Special tests: Bactericidal activity, activity of antimicrobics in combination, and detection of beta-lactamase production , in Lennette EH, Balows A, Hausler WJ Jr, et al (eds): Manual of Clinical Microbiology , ed 3. Washington, DC, American Society for Microbiology, 1980;, pp 478-481.
Vianna NJ, Kaye D:  Penetration of cephalothin into the spinal fluid . Am J Med Sci 1967;;254:216-220.
Lerner PI:  Penetration of cephaloridine into cerebrospinal fluid . Am J Med Sci 1971;;262:321-326.
Bassaris HP, Quintiliani R, Maderazo EG, et al:  Pharmacokinetics and penetration characteristics of cefazolin into human spinal fluid . Curr Ther Res 1976;;19:110-120.
Fisher LS, Chow AW, Yoshikawa TT, et al:  Cephalothin and cephaloridine therapy for bacterial meningitis: An evaluation . Ann Intern Med 1975;;82:689-693.
Walker SH, Collins CC:  Failure of cephaloridine in Haemophilus influenzae meningitis . Am J Dis Child 1968;;116:285-291.
Mangi RJ, Kundargi RS, Quintiliani R, et al:  Development of meningitis during cephalothin therapy . Ann Intern Med 1973;;78:347-351.
Lorber B, Santoro J, Swenson RM:  Listeria meningitis during cefazolin therapy . Ann Intern Med 1975;;82:226.
Steinberg EA, Overturf GD, Wilkins J, et al:  Failure of cefamandole in treatment of meningitis due to Haemophilus influenzae type b . J Infect Dis 1978;;137:S180-186.
Chartrand SA, Marks MI, Roberts R, et al:  Development of Haemophilus influenzae meningitis in patients treated with cefamandole . J Pediatr 1981;;98:1003-1005.
Bratton L, Teele DW, Klein JO:  Outcome of unsuspected pneumococcemia in children not initially admitted to the hospital . J Pediatr 1977;;90:703-706.
Marshall RE, Teele DW, Klein JO:  Unsuspected bacteremia due to Haemophilus influenzae: Outcome in children not initially admitted to hospital . J Pediatr 1979;;95:690-695.

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

References

Ginsburg CM, McCracken GH Jr:  Cefaclor and cefadroxil: A commentary on their properties and possible indications for use in pediatrics . J Pediatr 1980;;96:340-342.
Anhalt JP, Sabath LD, Barry AL:  Special tests: Bactericidal activity, activity of antimicrobics in combination, and detection of beta-lactamase production , in Lennette EH, Balows A, Hausler WJ Jr, et al (eds): Manual of Clinical Microbiology , ed 3. Washington, DC, American Society for Microbiology, 1980;, pp 478-481.
Vianna NJ, Kaye D:  Penetration of cephalothin into the spinal fluid . Am J Med Sci 1967;;254:216-220.
Lerner PI:  Penetration of cephaloridine into cerebrospinal fluid . Am J Med Sci 1971;;262:321-326.
Bassaris HP, Quintiliani R, Maderazo EG, et al:  Pharmacokinetics and penetration characteristics of cefazolin into human spinal fluid . Curr Ther Res 1976;;19:110-120.
Fisher LS, Chow AW, Yoshikawa TT, et al:  Cephalothin and cephaloridine therapy for bacterial meningitis: An evaluation . Ann Intern Med 1975;;82:689-693.
Walker SH, Collins CC:  Failure of cephaloridine in Haemophilus influenzae meningitis . Am J Dis Child 1968;;116:285-291.
Mangi RJ, Kundargi RS, Quintiliani R, et al:  Development of meningitis during cephalothin therapy . Ann Intern Med 1973;;78:347-351.
Lorber B, Santoro J, Swenson RM:  Listeria meningitis during cefazolin therapy . Ann Intern Med 1975;;82:226.
Steinberg EA, Overturf GD, Wilkins J, et al:  Failure of cefamandole in treatment of meningitis due to Haemophilus influenzae type b . J Infect Dis 1978;;137:S180-186.
Chartrand SA, Marks MI, Roberts R, et al:  Development of Haemophilus influenzae meningitis in patients treated with cefamandole . J Pediatr 1981;;98:1003-1005.
Bratton L, Teele DW, Klein JO:  Outcome of unsuspected pneumococcemia in children not initially admitted to the hospital . J Pediatr 1977;;90:703-706.
Marshall RE, Teele DW, Klein JO:  Unsuspected bacteremia due to Haemophilus influenzae: Outcome in children not initially admitted to hospital . J Pediatr 1979;;95:690-695.

Correspondence

CME
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.